LCE 125 (Stalevo 125 31.25 mg / 200 mg / 125 mg)
Generic Name: carbidopa/entacapone/levodopa
Pill imprint LCE 125 has been identified as Stalevo 125 31.25 mg / 200 mg / 125 mg.
Stalevo 125 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Stalevo 125 31.25 mg / 200 mg / 125 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LCE 125
- 31.25 mg / 200 mg / 125 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- corn starch
ferric oxide red
|NDC Code||Manufacturer / Repackager|
Note: Inactive ingredients may vary.
More about Stalevo 125 (carbidopa / entacapone / levodopa)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.